EyePoint Pharmaceuticals Ownership | Who Owns EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals Ownership Summary
EyePoint Pharmaceuticals is owned by 136.19% institutional investors, 1.16% insiders. Cormorant asset management, lp is the largest institutional shareholder, holding 15.29% of EYPT shares. Federated Hermes Kaufmann R is the top mutual fund, with 2.99% of its assets in EyePoint Pharmaceuticals shares.
EYPT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | EyePoint Pharmaceuticals | 136.19% | 1.16% | -37.35% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Cormorant asset management, lp | 8.32M | 15.29% | $62.02M |
Suvretta capital management | 6.78M | 12.46% | $50.53M |
Adage capital partners gp | 5.75M | 10.56% | $42.84M |
Blackrock funding, inc. /de | 5.28M | 9.70% | $39.35M |
Franklin resources | 4.14M | 7.60% | $30.82M |
Blackrock | 3.76M | 7.12% | $32.75M |
Vanguard group | 3.80M | 6.98% | $28.33M |
Federated hermes | 3.71M | 6.81% | $27.62M |
Tcg crossover management | 3.57M | 6.56% | $26.61M |
Ra capital management | 3.18M | 5.84% | $23.70M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Patient square capital lp | 1.41M | 3.93% | $10.51M |
Cormorant asset management, lp | 8.32M | 3.41% | $62.02M |
Tcg crossover management | 3.57M | 2.60% | $26.61M |
Ally bridge group (ny) | 348.00K | 2.22% | $2.59M |
Essex woodlands management | 1.17M | 2.01% | $8.72M |
5am venture management | 1.05M | 1.87% | $7.82M |
Suvretta capital management | 6.78M | 1.72% | $50.53M |
Blue owl capital lp | 667.59K | 1.15% | $4.97M |
Stempoint capital lp | 579.50K | 1.08% | $4.32M |
Artia global partners lp | 216.70K | 0.58% | $1.61M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ra capital management | 3.18M | 0.32% | 3.18M |
Tcg crossover management | 3.57M | 2.60% | 2.65M |
Adage capital partners gp | 5.75M | 0.07% | 1.96M |
Federated hermes | 3.71M | 0.06% | 1.78M |
Suvretta capital management | 6.78M | 1.72% | 1.61M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Octagon capital advisors lp | - | - | -1.09M |
T. rowe price investment management | 206.94K | 0.00% | -1.06M |
Deerfield management company, l.p. (series c) | - | - | -877.79K |
Fiera capital | - | - | -677.04K |
First turn management | - | - | -585.45K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Ra capital management | 3.18M | 0.32% | 3.18M | $23.70M |
Blue owl capital lp | 667.59K | 1.15% | 667.59K | $4.97M |
Nantahala capital management | 600.00K | 0.19% | 600.00K | $4.47M |
Stempoint capital lp | 579.50K | 1.08% | 579.50K | $4.32M |
Ally bridge group (ny) | 348.00K | 2.22% | 348.00K | $2.59M |
Sold Out
Holder | Change |
---|---|
Assetmark | -15.00 |
Continuum advisory | -16.00 |
Park place capital | -23.00 |
Russell investments group | -24.00 |
Principal securities | -24.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 148 | 2.78% | 74,156,377 | 26.76% | 136 | 1.18% | 95 | 41.79% | 24 | -52.00% |
Sep 30, 2024 | 143 | -8.92% | 58,500,958 | 0.17% | 107 | 0.88% | 68 | -26.09% | 48 | 9.09% |
Jun 30, 2024 | 157 | -10.29% | 58,402,790 | 6.20% | 110 | 1.02% | 92 | -21.37% | 44 | 18.92% |
Mar 31, 2024 | 175 | 12.90% | 54,991,981 | 11.00% | 103 | 0.75% | 117 | 25.81% | 37 | 5.71% |
Dec 31, 2023 | 155 | 42.20% | 49,541,998 | 47.02% | 117 | 1.52% | 93 | 45.31% | 35 | 75.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Federated Hermes Kaufmann R | 2.04M | 2.99% | 986.65K |
Federated Hermes Kaufmann Growth | 2.04M | 2.99% | 986.65K |
Vanguard Total Stock Mkt Idx Inv | 1.99M | 2.89% | - |
Franklin Biotechnology Discv A(acc)USD | 1.77M | 2.58% | - |
iShares Russell 2000 ETF | 1.73M | 2.52% | -15.02K |
Federated Hermes Kaufmann Small Cap Grow | 1.61M | 2.36% | 769.52K |
Federated Hermes Kaufmann Small Cap A | 1.61M | 2.36% | 769.52K |
Vanguard US Total Market Shares ETF | 1.56M | 2.27% | - |
Franklin US Small Cap Growth Equity | 1.18M | 1.73% | - |
Franklin Small Cap Growth Adv | 1.18M | 1.72% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 20, 2024 | DICICCO WENDY F | - | Buy | $20.00K |
Aug 21, 2024 | ANDO GORAN | - | Buy | $39.75K |
Aug 19, 2024 | Zaderej Karen L. | - | Buy | $99.75K |
Aug 16, 2024 | Lurker Nancy | - | Buy | $25.00K |
Jul 12, 2024 | GUYER DAVID R | - | Sell | $117.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q3 | 4 | 1 |
2024 Q2 | 4 | 2 |
2024 Q1 | 2 | 25 |
2023 Q4 | 18 | 10 |
EYPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools